Literature DB >> 29724652

A novel homozygous NDRG1 mutation in a Chinese patient with Charcot-Marie-Tooth disease 4D.

Bin Chen1, Songtao Niu1, Na Chen1, Hua Pan1, Xingao Wang1, Zaiqiang Zhang2.   

Abstract

Charcot-Marie-Tooth disease 4D (CMT4D) is characterized by severe peripheral neuropathy and deafness. It is caused by mutations in the N-myc downstream-regulated gene 1 (NDRG1). We report a Chinese man with a homozygous mutation c.675C > T of NDRG1 that resulted in Q185X, representing the third known CMT4D patient of non-European ancestry. The patient presented with a 15-year-long history of progressive limb weakness accompanied by hearing loss and dysarthria. There was abnormal differentiation and increased interpeak latencies in brainstem auditory evoked potentials. Compound muscle action potentials (CMAP) of the peripheral nerves were not elicited in distal segments, while prolonged distal latencies and decreased CMAP were present in proximal nerves. A mild enlargement of the lateral ventricles showed in brain magnetic resonance imaging studies. Q185X of NDRG1 is a novel mutation with CMT4D, which are demonstrated in Asian population. Q185X of the NDRG1 expands the clinical and mutational spectrum of CMT4D.
Copyright © 2018 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  CMT4D; NDRG1; Non-European population; Q185X

Mesh:

Substances:

Year:  2018        PMID: 29724652     DOI: 10.1016/j.jocn.2018.04.024

Source DB:  PubMed          Journal:  J Clin Neurosci        ISSN: 0967-5868            Impact factor:   1.961


  2 in total

1.  A splice altering variant in NDRG1 gene causes Charcot-Marie-Tooth disease, type 4D.

Authors:  Pooja Pravinbabu; Vikram V Holla; Prashant Phulpagar; Nitish Kamble; Manjunath Netravathi; Ravi Yadav; Pramod Kumar Pal; Babylakshmi Muthusamy
Journal:  Neurol Sci       Date:  2022-02-11       Impact factor: 3.307

2.  Aberrant Neuregulin 1/ErbB Signaling in Charcot-Marie-Tooth Type 4D Disease.

Authors:  Li-Ting Jiang; Yu-Hui Chen; Jie-Hong Huang; Wei-Fang Tong; Ling-Jing Jin; Li-Xi Li
Journal:  Mol Cell Biol       Date:  2022-06-16       Impact factor: 5.069

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.